Physician profile
David A Ray
NPI 1720062698
$601.85
in general payments reported to CMS, 2019-2025
17 companies · $31.24 in 2025
The $31.24 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.19 · 2020: $113 · 2021: $124 · 2022: $18.57 · 2023: $113 · 2024: $139 · 2025: $31.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $283.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $76.15 | 2019-2024 | Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $69.27 | 2020-2024 | Mounjaro |
| Abbvie INC. | $59.65 | 2021 | |
| Bardy Diagnostics, INC. | $50.00 | 2021 | |
| Novo Nordisk INC | $46.76 | 2023-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $43.07 | 2024 | |
| Janssen Pharmaceuticals, INC | $39.89 | 2023 | Xarelto |
| Abbott Laboratories | $39.21 | 2022-2023 | Gallant |
| Astrazeneca Pharmaceuticals Lp | $34.21 | 2019-2020 | |
| Optinose US, INC. | $27.63 | 2024 | |
| Astellas Pharma US INC | $23.09 | 2023 | Myrbetriq |
| Si-Bone, INC. | $19.82 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.94 | 2020 | |
| Inspire Medical Systems, INC. | $15.90 | 2025 | Inspire |
| Biohaven Pharmaceuticals, INC. | $14.58 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $13.74 | 2023 | |
| Eisai INC. | $12.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.